These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 19056315)

  • 41. The modulation of granulomatous tissue and tumour angiogenesis by diclofenac in combination with hyaluronan (HYAL EX-0001).
    Freemantle C; Alam CA; Brown JR; Seed MP; Willoughby DA
    Int J Tissue React; 1995; 17(4):157-66. PubMed ID: 8867646
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies.
    McDougall SR; Anderson AR; Chaplain MA
    J Theor Biol; 2006 Aug; 241(3):564-89. PubMed ID: 16487543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tumor angiogenesis].
    Bikfalvi A
    Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiogenesis and vascular targeting: relevance for hyperthermia.
    Horsman MR
    Int J Hyperthermia; 2008 Feb; 24(1):57-65. PubMed ID: 18214769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumorigenesis and the angiogenic switch.
    Bergers G; Benjamin LE
    Nat Rev Cancer; 2003 Jun; 3(6):401-10. PubMed ID: 12778130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biologic therapy of breast cancer: focus on co-inhibition of endocrine and angiogenesis pathways.
    Roy V; Perez EA
    Breast Cancer Res Treat; 2009 Jul; 116(1):31-8. PubMed ID: 19101790
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The platelet-derived growth factor receptor as a target for vascular endothelial growth factor-mediated anti-angiogenetic therapy in head and neck cancer.
    Bran B; Bran G; Hörmann K; Riedel F
    Int J Oncol; 2009 Jan; 34(1):255-61. PubMed ID: 19082496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular remodelling of an arterio-venous blood vessel network during solid tumour growth.
    Welter M; Bartha K; Rieger H
    J Theor Biol; 2009 Aug; 259(3):405-22. PubMed ID: 19371750
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposomes targeting tumour stromal cells.
    Kuijpers SA; Coimbra MJ; Storm G; Schiffelers RM
    Mol Membr Biol; 2010 Oct; 27(7):328-40. PubMed ID: 20939769
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Angiogenesis: all a radiation oncologist should know].
    Mazeron R; Bourhis J; Deutsch E
    Cancer Radiother; 2008 Jan; 12(1):50-60. PubMed ID: 18243753
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular and cellular regulators of cancer angiogenesis.
    Goh PP; Sze DM; Roufogalis BD
    Curr Cancer Drug Targets; 2007 Dec; 7(8):743-58. PubMed ID: 18220534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Site-specifically biotinylated VEGF(121) for near-infrared fluorescence imaging of tumor angiogenesis.
    Wang H; Chen K; Niu G; Chen X
    Mol Pharm; 2009; 6(1):285-94. PubMed ID: 19099493
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Thrombosis associated with angiogenesis inhibitors.
    Elice F; Rodeghiero F; Falanga A; Rickles FR
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):115-28. PubMed ID: 19285278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy.
    D'Onofrio A; Gandolfi A
    Math Med Biol; 2009 Mar; 26(1):63-95. PubMed ID: 19033598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy.
    Jain RK
    Nat Med; 2001 Sep; 7(9):987-9. PubMed ID: 11533692
    [No Abstract]   [Full Text] [Related]  

  • 56. Caveolae: mining little caves for new cancer targets.
    Carver LA; Schnitzer JE
    Nat Rev Cancer; 2003 Aug; 3(8):571-81. PubMed ID: 12894245
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular tumor targeting.
    Ahlskog J; Paganelli G; Neri D
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):296-309. PubMed ID: 17043627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vascular determinants of cancer stem cell dormancy--do age and coagulation system play a role?
    Rak J; Milsom C; Yu J
    APMIS; 2008; 116(7-8):660-76. PubMed ID: 18834410
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal effects of anti-angiogenesis therapy: update for the internist.
    Gurevich F; Perazella MA
    Am J Med; 2009 Apr; 122(4):322-8. PubMed ID: 19332223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.